KEVIN G WHERRY
Allopathic & Osteopathic Physicians|Internal Medicine MCMINNVILLE, OR NPI 1376869941
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine OR Amgen Inc. All categories
General Payments — all program years on this page
$725.54
- Category: General Payments
- Program years: PY2018–2024
- Record count: 43
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $153.12 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $153.12 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $59.66 | 4 |
| GlaxoSmithKline, LLC. | $24.97 | 1 |
| ABBVIE INC. | $21.79 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.30 | 1 |
| Acerta Pharma LLC | $15.72 | 1 |
| Astellas Pharma US Inc | $13.68 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1105264498 | AstraZeneca Pharmaceuticals LP | $15.72 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1106330677 | ABBVIE INC. | $21.79 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111738572 | Amgen Inc. | $14.89 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111738574 | Amgen Inc. | $15.61 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111738576 | Amgen Inc. | $14.28 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111738578 | Amgen Inc. | $14.88 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1115853875 | GlaxoSmithKline, LLC. | $24.97 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117986857 | Boehringer Ingelheim Pharmaceuticals, Inc. | $17.30 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139348622 | Astellas Pharma US Inc | $13.68 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.